Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity

Cancer Research Institute (CRI)

The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity supports qualified young scientists from underrepresented minorities at leading universities and research centers around the world who wish to receive training in fundamental immunology and cancer immunology. Fellows train under the guidance of a world-renowned immunologist, who sponsors the fellow and prepares him or her for a productive and successful career in cancer immunology. The program will provide additional support for mentoring and career advancement to these individuals, as we work to build a more racially diverse and inclusive community of scientists working in immuno-oncology.

We invite applications from candidates who identify as Black or African American, Hispanic or Latino, or American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible.

CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.

A panel of scientists drawn from the CRI Scientific Advisory Council will rigorously evaluate each candidate, the intended sponsor and training environment, and the nature and feasibility of the proposed project.

Financial Information

Fellowships are for three years. Beginning with the March 1, 2023, deadline (for new awards beginning July 1, 2023), newly awarded fellowships provide a stipend of $74,000 for the first year, $76,000 for the second year, and $78,000 for the third year. An allowance of $5,000 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, health insurance, and/or childcare. CRI provides additional support for fellows to attend CRI’s annual International Cancer Immunotherapy Conference (CICON), and to participate in CRI’s soon-to-be-launched Bioinformatics Bootcamp.

Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. Payments are made monthly in U.S. currency to the host institution.

Deadlines

The application deadlines are March 1 and September 1; when those dates fall on the weekend, applications are due the following Monday. Applications are due by 11:59 p.m. Eastern Time on these dates. Applicants are notified of fellowship committee decisions within approximately 10-12 weeks of the application deadline.

Fellowships can be activated four months after the application deadline but no later than one year following the deadline. Awards activate on the first of the month.

Instructions for Applying

The application process requires you to access CRI’s Application Portal for institutional signatures and certification.

Specialties

Cancer

Oncology

Immunology

Eligibility Requirements

The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity is open to candidates who identify as Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible.
To be eligible, an applicant must be working at a nonprofit institution in the United States or abroad.
Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
Applicants with 5 or more years of relevant postdoctoral experience at the time of award activation are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
The fellowship can be performed in the United States or abroad but must take place at a non-profit institution. There are no citizenship restrictions.
Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
Resubmissions: Applicants are permitted to resubmit their fellowship application at a subsequent deadline provided that the new application is improved to reflect progress. Changes to the application should be addressed in the subsequent application.

Sponsor Details

Sponsor Institute/Organizations: Cancer Research Institute (CRI)

Sponsor Type:

Address: 29 Broadway, Floor 4 New York, NY 10006-3111

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity